Serious gaps: How the lack of sex/gender-based research impairs health

Journal of Women's Health

Volumn 15, Issue 10, 2006, Pages 1112-1122

  Correa de Araujo, Rosaly ^a  

^a U S DEPARTMENT OF HEALTH AND HUMAN SERVICES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTILIPEMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FIBRINOGEN RECEPTOR ANTAGONIST;

ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL PRACTICE; CLINICAL RESEARCH; COMMUNITY CARE; DECISION MAKING; HEALTH CARE DELIVERY; HEALTH CARE NEED; HEALTH CARE POLICY; HEALTH CARE QUALITY; HEALTH CARE SYSTEM; HEALTH PRACTITIONER; HEALTH SERVICE; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; PRIORITY JOURNAL; RISK REDUCTION; SCIENTIST; SEX DIFFERENCE; SOCIAL STATUS; SOCIAL SUPPORT; WELLBEING; EVIDENCE BASED MEDICINE; FEMALE; GENDER IDENTITY; HEALTH STATUS; HEALTH SURVEY; MALE; METHODOLOGY; REVIEW; STANDARD; UNITED STATES; WOMEN'S HEALTH;

CARDIOVASCULAR DISEASES; EVIDENCE-BASED MEDICINE; FEMALE; GENDER IDENTITY; HEALTH POLICY; HEALTH STATUS; HEALTH STATUS INDICATORS; HUMANS; MALE; RESEARCH DESIGN; UNITED STATES; WOMEN'S HEALTH;

EID: 33846489049     PISSN: 15409996     EISSN: None     Source Type: Journal    
DOI: 10.1089/jwh.2006.15.1116     Document Type: Article

References (44)

1. Institute of Medicine. Implications of genomics for public health. Workshop summary. Washington, DC: National Academy Press, 2005.
2. Public Health Report. Women's health. Report of the Public Health Service Task Force on Women's Health Issues. Washington, DC. 1985;100:73.
3. Revitalization Act of 1993, PL 103-43. Available at grants.nih.gov/ grants/funding/women_min/guidelines_amended_10_2001.htm001.htm
4. U.S. Food and Drug Administration. Guideline for the study and evaluation of gender differences in the clinical evaluation of drugs; notice. Fed Regist 1993; 58:39406.
5. U.S. Centers for Disease Control and Prevention, U.S. Agency for Toxic Substances and Disease Registry. Policy on the inclusion of women and racial and ethnic minorities in externally awarded research; notice. Fed Regist 1995;60:47947. Available at www.cdc.gov/od/ads/docs/wominext.pdf
6. U.S. Centers for Disease Control and Prevention. Inclusion of women and racial and ethnic minorities in research. Manual Guide General Administration CDC-80. 2/16/96. Available at www.cdc.gov/od/foia/ policies/inclusio.pdf
7. Healthcare Research and Quality Act of 1999. Available at www.ahrq.gov/ hrqa99a.htm
8. Institute of Medicine. Exploring the biological contributions to human health: Does sex matter? Washington, DC: National Academy Press, 2001. Available at www.iom.edu/CMS/3740/5437.aspx
9. General Accounting Office. Women's Health. NIH has increased its efforts to include women in clinical trials. Washington DC: GAO, 2000. Available at www.gao.gov/archive/2000/he00096.pdf
10. Agency for Healthcare Research and Quality. Agency for Healthcare Research and Quality policy on the inclusion of priority populations in research. Rockville, MD: AHRQ, 2003. Available at grants.nih.gov/grants/ guide/notice-files/NOT-HS-03-010.html
11. Sutter Heart Institute. Available at sutterheartinstitute.org/conditions/ women.html
12. Vaccarino V, Krumholz HM, Yarzebski J, Gore JM, Goldberg RJ. Sex differences in 2-year mortality after hospital discharge for myocardial infarction. Ann Intern Med 2002;134:173.
13. McSweeney JC, Cody M, O'Sullivan P, Elberson K, Moser DK, Garvin BJ. Women's early warning symptoms of acute myocardial infarction. Circulation 2003;108:2619.
14. Labiche LA, Chan W, Saldin KR, Morgenstern LB. Sex and acute stroke presentation. Ann Emerg Med 2002;40:453.
15. Seils DM, Friedman JY, Schulman RA. Sex differences in the referral process for invasive cardiac procedures. J Am Med Women Assoc 2001;6:151.
16. Bello N, Mosca L. Epidemiology of coronary heart disease in women. Prog Cardiovasc Dis 2004;46:287.
17. Glynn RJ, L'Italien GJ, Sesso HD, Jackson EA, Buring JE. Development of predictive models for long-term cardiovascular risk associated with systolic and diastolic blood pressure. Hypertension 2002;39:105.
18. Coulston AM. Insulin resistance and type 2 diabetes mellitus: Gender differences and similarities. In: Legato MJ, ed. Principles of gender-specific medicine. Oxford, UK: Elsevier Academic Press, 2004, vol 2:752.
19. Sharrett AR, Ballantyne CM, Coady SA, et al. Atherosclerosis risk in communities study group. Coronary heart disease prediction from lipoprotein cholesterol levels, triglycerides, lipoprotein(a), apolipoproteins A-I and B, and HDL density subfractions: The Atherosclerosis Risk in Communities (ARIC) Study. Circulation 2001;104:1108.
20. Results of systematic review of research on diagnosis and treatment of coronary heart disease in women. Summary, Evidence Report/Technology Assessment Number 80. AHRQ Publication No. 03-E034. Rockville, MD: AHRG, 2003. Available at www.ahrq.gov/clinic/epcsums/chdwomsum.htm
21. Diagnosis and treatment of coronary heart disease in women: Systematic reviews of evidence on selected topics. Summary, Evidence Report/ Technology Assessment Number 81. AHRQ Publication No. 03-E036. Rockville, MD: AHRQ, 2003. Available at www.ahrq.gov/c/inic/epcsums/ chdwtopsum
22. Ridker PM, Cook NR, Lee IM, et al. A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women. N Engl J Med 2005;352:1293.
23. Schulman KA, Berlin JA, Harless W, et al. The effect of race and sex on physicians' recommendations for cardiac catheterization. N Engl J Med 1999;340:618. Erratum: N Engl J Med 1999;340:1130.
24. Glader EL, Stegmayr B, Norrving B, et al. Sex differences in management and outcome after stroke: A Swedish national perspective. Stroke 2003;34: 1970.
25. Kent DM, Price LL, Ringleb P, Hill MD, Selker HP. Sex-based differences in response to recombinant tissue plasminogen activator in acute ischemic stroke: A pooled analysis of randomized clinical trials. Stroke 2005;36:62.
26. Correa-de-Araujo R, Stevens B, Moy E, Nilasena D, Chesley F, McDermott K. Gender differences across racial and ethnic groups in the quality of care for acute myocardial infarction and heart failure associated with comorbidities. Womens Health Issues 2006; 16:44.
27. Humphries KH, Kerr CR, Connolly SJ, et al. New-on-set atrial fibrillation: Sex differences in presentation, treatment, and outcome. Circulation 2001;103:2365.
28. Mosca I, Merz NB, Blumenthal RS, et al. Opportunity for intervention to achieve American Heart Association Guidelines for optimal lipid levels in high-risk women in managed care setting. Circulation 2005; 111:488.
29. Corbelli JA, Corbelli JC, Bullano MF, et al. Gender bias in lipid assessment and treatment following percutaneous coronary intervention. J Gend Specific Med 2003;6:21.
30. Kim C, Kerr EA, Bernstein SJ, Krein SL. Gender disparities in lipid management: The presence of disparities depends on the quality measure. Am J Managed Care 2006;12:133.
31. Krobot KJ, Yin DD, Alemao E, Steinhagen-Thiessen E. Real-world effectiveness of lipid-lowering therapy in male and female outpatients with coronary heart disease: Relation to pre-treatment low-density lipoprotein-cholesterol, pre-treatment coronary heart disease risk, and other factors. Eur J Cardiovasc Prev Rehabil 2005;12:37.
32. Wang TJ, Varan RS. Epidemiology of uncontrolled hypertension in the United States. Circulation 2005; 112:1651.
33. Rossouw JE, Anderson GL, Prentice RL, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: Principal results from the Women's Health Initiative randomized controlled trial. JAMA 2002;288:321.
34. Legato MJ. Why do we need an Association for Gender-Specific Medicine? J Gend Specif Med 2003;6:4.
35. Bird CE. Women and health research. In: Institute of Medicine. Worship and commissioned papers. Washington, DC: National Academy Press, 1994: vol 2.
36. Grant K. Gender-based analysis: Beyond the red queen syndrome. Centres of Excellence for Women's Health Research Bulletin 2002;2:16.
37. Breen N. Social discrimination and health: Gender, race, and class in the United States. In: Sen G, George A, Ostlin P, eds. Engendering international health. Cambridge, MA: Massachusetts Institute of Technology Press, 2002:223.
38. Ashton CM, Haidet PI, Paterniti DA, et al. Racial and ethnic disparities in the use of health services: Bias, preferences, or poor communication? J Gen Intern Med 2003;18:146.
39. van Ryn M. Research on the provider contribution to race/ethnicity disparities in medical care. Med Care 2002;40:140.
40. Kopp MS, Skrabski A, Kawachi I, Adler NE. Low socioeconomic status of the opposite sex is a risk factor for middle aged mortality. J Epidemiol Community Health 2005;59:675.
41. Institute of Medicine. Health and behavior: The interplay of biological, behavioral and societal influences. In: Committee on Health and Behavior. Research practice, and policy board on neuroscience and behavioral health. Washington, DC: National Academy Press, 2001:377.
42. Bird CE, Rieker PP. Integrating social and biological research to improve men's and women's health. Womens Health Issues 2002;2:113.
43. Jamison DT, Breman JG, Measham AR, et al., eds. Disease control priorities in developing countries, 2nd ed. Oxford; Washington, DC: The International Bank for Reconstruction and Development/The World Bank. 2006:195.
44. Geller SE, Adams MG, Carnes M. Adherence to federal guidelines for reporting of sex and race/ethnicity in clinical trials. J Women's Health 2006;15:1123.